Frontorhiny
Description
Frontorhiny is a distinct syndromic type of frontonasal malformation characterized by hypertelorism, wide nasal bridge, broad columella, widened philtrum, widely separated narrow nares, poor development of nasal tip, midline notch of the upper alveolus, columella base swellings and a low hairline. Additional features reported in some include upper eyelid ptosis and midline dermoid cysts of craniofacial structures and philtral pits or rugose folding behind the ears. An autosomal recessive inheritance has been proposed.
Clinical Features
Top most frequent phenotypes and symptoms related to Frontorhiny
- Scoliosis
- Hypertelorism
- Strabismus
- Cleft palate
- Cataract
- Ptosis
- Epicanthus
- Brachydactyly
- Microphthalmia
- Low-set, posteriorly rotated ears
And another 19 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Frontorhiny Is also known as frontonasal dysplasia type 1, isolated median cleft face syndrome, alx3-related frontonasal dysplasia.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Frontorhiny Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Craniofacial Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
RUNX2, SKI, TCF12, TGFBR1, TGFBR2, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, CDC45, WDR19, FAM20C, WDR35, IFT43, DPH1, EFNB1, MEGF8, ERF , (...)
View the complete list with 11 more genes
Specificity
4 %
Genes
100 % |
Craniofacial Deletion/Duplication Panel.
By Genetic Services Laboratory University of Chicago (United States).
RUNX2, SKI, TCF12, TGFBR1, TGFBR2, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, CDC45, WDR19, FAM20C, WDR35, IFT43, DPH1, EFNB1, MEGF8, ERF , (...)
View the complete list with 11 more genes
Specificity
4 %
Genes
100 % |
Facial Dysostosis Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
SF3B4, TCOF1, ALX1, EVC2, POLR1C, POLR1D, CHD7, DHODH, ZSWIM6, EFTUD2, EFNB1, EVC, ALX3, ALX4, MYCN, PDE4D, PRKAR1A
Specificity
6 %
Genes
100 % |
ALX3. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ALX3
Specificity
100 %
Genes
100 % |
ALX3. MLPA testing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ALX3
Specificity
100 %
Genes
100 % |
Craniofacial Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
RUNX2, SALL1, SF3B4, SIX1, SIX5, SKI, SNRPB, TCF12, TCOF1, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, POLR1A, WDR19, EVC2, POLR1C, POLR1D , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
100 % |
Craniofacial Seq + Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
RUNX2, SALL1, SF3B4, SIX1, SIX5, SKI, SNRPB, TCF12, TCOF1, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, POLR1A, WDR19, EVC2, POLR1C, POLR1D , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
100 % |
Craniofacial Seq Analysis.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
RUNX2, SALL1, SF3B4, SIX1, SIX5, SKI, SNRPB, TCF12, TCOF1, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, POLR1A, WDR19, EVC2, POLR1C, POLR1D , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
100 % |
You can get up to 20 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY FRUCTOSURIA, ESSENTIAL LIMITED CUTANEOUS SYSTEMIC SCLEROSIS NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4